Mirtazapine
Product Images NDC 67046-484

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 67046-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine 30 mg #30 (Mirtazapine Fig5)

Mirtazapine 30 mg #30 (Mirtazapine Fig5)
This is a prescription medication with a dosage of 30mg mirtazapine per tablet. It is important to read the enclosed prescribing information. The medication is packaged in a container with the LOT number 17147J and pill ID AQY. It was packaged by Contract Pharmacy Services in Warrington, PA. The medication should be stored at a temperature of 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The medication is for prescription use only. The expiration date is 12/01/117.*
FDA Label Image

Mirtazapine 45 mg #30 (Mirtazapine Fig7)

Mirtazapine 45 mg #30 (Mirtazapine Fig7)
MIRTAZAPINE 45 MG tablets packaged by AUROBINDO. Each blister pack contains 30 tablets with LOT number XXX, expiring on 08/03/17. The tablets are prescribed medication (Rx Only) for which enclosed prescribing information is available. The tablets should be stored at temperatures between 15-30°C (59-86°F). The pill identifier is A 10 and CPSNDC is 67046-478-30.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.